Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| basal cell | 6 studies | 34% ± 20% | |
| keratinocyte | 5 studies | 70% ± 19% | |
| epithelial cell | 4 studies | 41% ± 25% | |
| respiratory goblet cell | 3 studies | 47% ± 9% | |
| secretory cell | 3 studies | 20% ± 1% | |
| squamous epithelial cell | 3 studies | 27% ± 11% | |
| club cell | 3 studies | 45% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| skin | 3 studies | 35% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 39% | 16231.37 | 559 / 1445 | 60% | 263.31 | 109 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 712.66 | 42 / 45 |
| skin | 71% | 13403.98 | 1289 / 1809 | 10% | 16.11 | 48 / 472 |
| bladder | 19% | 1831.62 | 4 / 21 | 45% | 309.01 | 229 / 504 |
| uterus | 1% | 244.72 | 2 / 170 | 62% | 539.69 | 283 / 459 |
| adrenal gland | 42% | 896.31 | 109 / 258 | 18% | 21.65 | 42 / 230 |
| pancreas | 0% | 0 | 0 / 328 | 30% | 77.17 | 54 / 178 |
| lung | 0% | 0 | 0 / 578 | 26% | 74.82 | 303 / 1155 |
| breast | 0% | 2.78 | 1 / 459 | 8% | 11.73 | 86 / 1118 |
| prostate | 7% | 293.27 | 16 / 245 | 1% | 0.37 | 5 / 502 |
| intestine | 0% | 0 | 0 / 966 | 7% | 17.22 | 39 / 527 |
| stomach | 1% | 45.95 | 3 / 359 | 4% | 3.72 | 12 / 286 |
| thymus | 0% | 0 | 0 / 653 | 1% | 1.60 | 8 / 605 |
| ovary | 0% | 0 | 0 / 180 | 1% | 0.36 | 4 / 430 |
| kidney | 0% | 0 | 0 / 89 | 0% | 1.63 | 4 / 901 |
| adipose | 0% | 18.81 | 4 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 0% | 4.23 | 2 / 803 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0.11 | 1 / 406 |
| blood vessel | 0% | 10.11 | 3 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.88 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| brain | 0% | 0 | 0 / 2642 | 0% | 0 | 0 / 705 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0035634 | Biological process | response to stilbenoid |
| GO_0007155 | Biological process | cell adhesion |
| GO_0030098 | Biological process | lymphocyte differentiation |
| GO_0009986 | Cellular component | cell surface |
| GO_0098552 | Cellular component | side of membrane |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LY6D |
| Protein name | Lymphocyte antigen 6D (Ly-6D) (E48 antigen) |
| Synonyms | E48 |
| Description | FUNCTION: May act as a specification marker at earliest stage specification of lymphocytes between B- and T-cell development. Marks the earliest stage of B-cell specification. |
| Accessions | ENST00000301263.5 Q14210 |